Driving with Type 1 Diabetes: Real-World Evidence to Support Starting Glucose Level and Frequency of Monitoring During Journeys

There is limited evidence supporting the recommendation that drivers with insulin-treated diabetes need to start journeys with glucose >90 mg/dL. Glucose levels of drivers with type 1 diabetes were monitored for 3 weeks using masked continuous glucose monitoring (CGM). Eighteen drivers (median [I...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes technology & therapeutics 2022-05, Vol.24 (5), p.350-356
Hauptverfasser: Trawley, Steven, Stephens, Amanda N, McAuley, Sybil A, Speight, Jane, Hendrieckx, Christel, Vogrin, Sara, Lee, Melissa H, Paldus, Barbora, Bach, Leon A, Burt, Morton G, Cohen, Neale D, Colman, Peter G, Davis, Elizabeth A, Holmes-Walker, D Jane, Jenkins, Alicia J, Kaye, Joey, Keech, Anthony C, Kumareswaran, Kavita, MacIsaac, Richard J, McCallum, Roland W, Sims, Catriona M, Stranks, Stephen N, Sundararajan, Vijaya, Ward, Glenn M, Jones, Timothy W, O'Neal, David N
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:There is limited evidence supporting the recommendation that drivers with insulin-treated diabetes need to start journeys with glucose >90 mg/dL. Glucose levels of drivers with type 1 diabetes were monitored for 3 weeks using masked continuous glucose monitoring (CGM). Eighteen drivers (median [IQR] age 40 [35, 51] years; 11 men) undertook 475 trips (duration 15 [13, 21] min). Hypoglycemia did not occur in any trip starting with glucose >90 mg/dL (92%;  = 436). Thirteen drivers recorded at least one trip (total  = 39) starting with glucose
ISSN:1520-9156
1557-8593
DOI:10.1089/dia.2021.0460